ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
34,450
+750 (2.23%)
Mar 31, 2025, 3:30 PM KST

ABL Bio Revenue

In the year 2024, ABL Bio had annual revenue of 33.40B KRW, down -49.04%. ABL Bio had revenue of 9.09B in the quarter ending December 31, 2024, with 13.52% growth.

Revenue
33.40B
Revenue Growth
-49.04%
P/S Ratio
49.53
Revenue / Employee
327.48M
Employees
102
Market Cap
1,671.79B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202433.40B-32.14B-49.04%
Dec 31, 202365.55B-1.75B-2.61%
Dec 31, 202267.30B61.97B1,162.19%
Dec 31, 20215.33B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition